Form 4: Elanco Chief Accounting Officer Disposes of Shares for Tax Obligations

Elanco Animal Health Inc.'s Chief Accounting Officer, James M. Meer, disposed of 1,161 shares of common stock on July 3, 2025, to cover tax obligations related to vested restricted stock units.

Summary

• James M. Meer, Elanco Animal Health Inc.'s Chief Accounting Officer, disposed of 1,161 shares of Elanco common stock.
• The transaction occurred on July 3, 2025, at a price of $14.64 per share.
• The shares were tendered to the company to cover tax liability upon the vesting of previously awarded restricted stock units under the Amended and Restated 2018 Elanco Stock Plan.
• Following this transaction, James M. Meer directly beneficially owns 58,103 shares of Elanco common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction for tax purposes related to executive compensation, which is neither inherently positive nor negative for the company's fundamental outlook.

Positives

• Vesting of restricted stock units indicates the fulfillment of equity compensation terms, aligning executive interests with shareholder value.

Negatives

• The disposition of shares, even for tax purposes, reduces the direct ownership stake of a key executive, though this is a common practice for equity compensation.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, common across all industries for publicly traded companies with equity incentive plans. It does not provide specific insights into the animal health industry trends or Elanco's competitive position.

Comparison to Industry Standards

• This transaction is a standard practice for executives receiving equity compensation, where a portion of vested shares is sold or withheld to cover tax liabilities. This is consistent with compensation practices observed in other large pharmaceutical and animal health companies like Zoetis Inc. or Merck Animal Health, where executives often manage their equity awards through similar tax-related dispositions.

Stakeholder Impact

• Shareholders: Minimal direct impact. This is a small, routine disposition by an executive, not indicative of a change in confidence or strategy.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

Keywords

Elanco Animal Health Inc., ELAN, Form 4, Insider Transaction, Stock Disposition, Restricted Stock Units, Tax Liability, Executive Compensation, James M. Meer, Chief Accounting Officer